Drug intelligence / Profile preview

vinburnine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Vinburnine is a vinca alkaloid derivative, specifically the oxidized form of vincamine, traditionally utilized as a vasodilator for the treatment of cerebrovascular disorders and cognitive impairment. In recent oncological research, vinburnine has demonstrated potential as an antineoplastic agent in melanoma. Its mechanism involves the induction of reactive oxygen species (ROS), which leads to DNA damage and triggers the apoptotic cascade. Furthermore, it activates the P38/MAPK/ATF3 signaling axis, resulting in the secretion of interleukin-24 (IL-24). This process enhances CD8+ T cell activity and modulates the tumor immune microenvironment, showing synergistic potential when combined with anti-PD-1 immunotherapy.

Brand names
CervoxanVincaneEburnal
Other names
eburnamoninevincamonine(-)-eburnamonine
02

Targets

DNAMAPK14 (p38 mitogen-activated protein kinase alpha)ATF3 (Cyclic AMP-dependent transcription factor ATF-3)

Beyond the preview

Go deeper on vinburnine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vinburnine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call